<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Screening for unhealthy use of alcohol and other drugs in primary care</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Screening for unhealthy use of alcohol and other drugs in primary care</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Screening for unhealthy use of alcohol and other drugs in primary care</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew J Saxon, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Murray B Stein, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Friedman, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 11, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H2788933"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Unhealthy alcohol and other drug use are among the most common causes of preventable death [<a href="#rid1">1</a>]. “Unhealthy use” describes use of amounts that risk consequences or have resulted in consequences. Additionally, unhealthy use includes those individuals diagnosed with an American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR) substance use disorder [<a href="#rid2">2</a>].</p><p>Despite their frequent presentation in primary care, unhealthy alcohol and other drug use often go unrecognized. The combination of screening all adult primary care patients to identify individuals with unhealthy use and a brief counseling intervention has been proposed as a population-wide, preventive intervention in primary care [<a href="#rid3">3</a>]. Clinical trials support the use of screening and brief intervention in adults who have unhealthy alcohol use but not a moderate to severe alcohol use disorder. Screening is also the first step in identifying patients with a substance use disorder.</p><p>This topic reviews screening tests for unhealthy alcohol and other drug use in primary care. Treatment of patients screening positive with a brief intervention and the efficacy of screening combined with a brief intervention are described separately. The epidemiology, clinical manifestations, and diagnosis of substance use disorders are described separately, as are pharmacotherapy and psychosocial interventions for the disorders.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">"Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7810.html" rel="external">"Alcohol use disorder: Psychosocial management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7804.html" rel="external">"Opioid use disorder: Epidemiology, clinical features, health consequences, screening, and assessment"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7803.html" rel="external">"Opioid use disorder: Pharmacologic management"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7796.html" rel="external">"Cannabis use disorder: Clinical features, screening, diagnosis, and treatment"</a>.)</p><p></p><p class="headingAnchor" id="H114013009"><span class="h1">DEFINITIONS</span></p><p class="headingAnchor" id="H114013115"><span class="h2">Risky use</span><span class="headingEndMark"> — </span>Risky use of alcohol or other drugs is defined as consumption amounts that increase the likelihood of health consequences (eg, injury, interpersonal problems, medical consequences). (See <a class="local">'Medical consequences'</a> below.)</p><p class="headingAnchor" id="H114013246"><span class="h3">Alcohol</span><span class="headingEndMark"> — </span>The National Institute on Alcohol Abuse and Alcoholism (NIAAA) in the United States estimates amounts of alcohol that increase health risks below [<a href="#rid4">4</a>]. Specifying these thresholds is an inexact science based on epidemiological evidence. Amounts are based on a “standard drink,” which is defined as 12 grams of ethanol, 5 ounces of wine, 12 ounces of beer, or 1.5 ounces of 80 proof spirits.</p><p class="bulletIndent1"><span class="glyph">●</span>Men under age 65 – More than 14 standard drinks per week on average</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>More than four drinks on any day</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Women and adults 65 years and older – More than seven standard drinks per week on average</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>More than three drinks on any day</p><p></p><p>Drink size and assessment items for unhealthy use can vary internationally.</p><p class="headingAnchor" id="H114013253"><span class="h3">Other drugs</span><span class="headingEndMark"> — </span>There are no widely agreed upon standards for unhealthy use of other drugs. However, any amounts of some drugs are unhealthy. As examples, a single use of cocaine can lead to myocardial infarction, and any injection drug use can lead to HIV infection. One might assume any use risks health consequences, particularly if one includes legal consequences, or the risk of developing addiction, in the definition of health. (See  <a class="medical medical_review" href="/z/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2788940"><span class="h2">Unhealthy alcohol or drug use</span><span class="headingEndMark"> — </span>Unhealthy use refers to the spectrum of use that can result in health consequences [<a href="#rid5">5</a>]. As such, it includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Use of amounts that risk consequences. (See <a class="local">'Risky use'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use that has already resulted in consequences but not yet a diagnosable disorder (often referred to as problem use, misuse, or hazardous use). These terms can be confusing as they are sometimes used to refer to the full spectrum of unhealthy use.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use accompanied by features meeting DSM-5-TR diagnostic criteria for substance use disorder [<a href="#rid2">2</a>]. (See <a class="local">'Substance use disorder'</a> below.)</p><p></p><p class="headingAnchor" id="H1271782"><span class="h1">PREVALENCE OF UNHEALTHY USE</span><span class="headingEndMark"> — </span>Fully 28 percent of adults in the United States have unhealthy alcohol use; 25 percent of those age 12 and older report “binge” alcohol use in the past month (five or more standard drinks for males, four or more for females on an occasion), and in a national survey, 24.9 percent report any illicit drug use in the past year, including nonmedical use of prescription drugs [<a href="#rid5">5,6</a>]. These numbers are much greater than for alcohol and drug use disorders – the most clinically obvious conditions in the spectrum of unhealthy use. A general population survey found that 13 percent of adults in the United States had alcohol use disorder in the last 12 months [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">"Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"</a>.)</p><p>Those with nondependent unhealthy use account for more morbidity, mortality, and cost than do the smaller number of people at the more severe end of the spectrum [<a href="#rid8">8</a>]. Patients across the spectrum of unhealthy use often go unrecognized as having an alcohol or other drug problem, and therefore go untreated.</p><p class="headingAnchor" id="H522927"><span class="h1">INDICATIONS</span><span class="headingEndMark"> — </span>The United States Preventive Services Task Force (USPSTF) has recommended that all adults in primary care be screened to identify unhealthy alcohol use and that those with unhealthy use receive a brief counseling intervention [<a href="#rid9">9</a>]. The combined efficacy of screening and brief intervention is described separately. (See  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration", section on 'Efficacy'</a> and  <a class="medical medical_review" href="/z/d/html/6486.html" rel="external">"Ethanol intoxication in children: Epidemiology, estimation of toxicity, and toxic effects"</a> and  <a class="medical medical_review" href="/z/d/html/2872.html" rel="external">"Screening tests in children and adolescents", section on 'Nicotine, alcohol, and substance use'</a> and  <a class="medical medical_review" href="/z/d/html/108.html" rel="external">"Guidelines for adolescent preventive services", section on 'Screening'</a>.)</p><p>The USPSTF also recommends screening for unhealthy use of drugs other than alcohol when services are in place to ensure follow-up for diagnosis and treatment [<a href="#rid10">10</a>]. Screening is performed by asking questions about illegal drugs and prescription medications that are not used for medical purposes (see <a class="local">'Screening tests'</a> below). However, no randomized trials have found that screening reduces drug use, morbidity, or mortality [<a href="#rid11">11</a>]. In addition, clinical trials have not consistently found brief intervention to be effective for use of substances other than alcohol or for any substance use disorder [<a href="#rid12">12,13</a>]. Nevertheless, screening is a reasonable clinical practice for identifying comorbidity, informing use of addictive medications, and diagnosing related conditions [<a href="#rid12">12</a>]. (See  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration", section on 'Efficacy'</a>.)</p><p class="headingAnchor" id="H2788947"><span class="h1">SCREENING TESTS</span><span class="headingEndMark"> — </span>Screening is insufficient for someone already known to have unhealthy substance use. For these patients, a full assessment for substance use disorders is more appropriate. The best approach to screening in primary care is to use a brief, simple set of questions that is validated in the setting for its intended use and that identifies the full spectrum of unhealthy use. Brief questionnaires are easier for clinicians to memorize and use. Some longer, more complex tools (eg, with multiple response options that require scoring) provide assessment or risk information that can be useful for brief intervention, but that benefit may be outweighed by the added burden.</p><p>Many tools are available for detecting unhealthy alcohol use. Fewer are available for drug use and for nonmedical use of prescription drugs (use for the feeling it causes). Most screening questionnaires are validated against diagnostic interview reference standards, though some add laboratory testing or future consequences to these reference standards. In part because of limitations with laboratory testing, the best reference standard for current unhealthy substance use is a diagnostic interview (to identify substance use disorders) and a calendar-based questionnaire to determine consumption [<a href="#rid14">14,15</a>]. Ideally, the questionnaire used for screening for unhealthy use would be one that was used in trials that demonstrate efficacy of brief intervention. (See  <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">"Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"</a> and  <a class="medical medical_review" href="/z/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7804.html" rel="external">"Opioid use disorder: Epidemiology, clinical features, health consequences, screening, and assessment"</a> and  <a class="medical medical_review" href="/z/d/html/7796.html" rel="external">"Cannabis use disorder: Clinical features, screening, diagnosis, and treatment"</a>.)</p><p class="headingAnchor" id="H2788954"><span class="h2">Unhealthy alcohol use</span><span class="headingEndMark"> — </span>For screening adults for unhealthy alcohol use in primary care, we suggest the use of single-item screening. The Alcohol Use Disorders Identification Test (AUDIT)-C, which has some advantages over the single-item test, may be made feasible for use in some settings, eg, if embedded with associated decision support in an electronic health record (EHR). Although other screening tests have been validated, none have advantages over the single item screening, the AUDIT-C, and the AUDIT for use in primary care settings.</p><p class="headingAnchor" id="H20772335"><span class="h3">Single-item screening</span><span class="headingEndMark"> — </span>Several single-item alcohol screening questions have been proposed and tested [<a href="#rid16">16-20</a>]. They are brief, memorizable, and require no scoring. One, validated in primary care in a single cross-sectional study [<a href="#rid19">19</a>], is asked following the introductory question, “Do you sometimes drink beer, wine or other alcoholic beverages?”:</p><p class="bulletIndent1"><span class="glyph">●</span>How many times in the past year have you had five (four for women) or more drinks in a day?</p><p></p><p>The test is scored positive when the response is greater than 0 or when the patient states they are having difficulty coming up with the correct number (because it is therefore greater than 0). A positive test is 82 percent sensitive and 79 percent specific for unhealthy alcohol use. In a two-site cross sectional study of 459 adult primary care patients, the item was similarly accurate when self-administered on touchscreen tablet computers [<a href="#rid21">21</a>].</p><p class="headingAnchor" id="H1272399"><span class="h3">AUDIT-C</span><span class="headingEndMark"> — </span>The AUDIT-C is a screening test comprised of three items on excess consumption from the AUDIT  (<a class="graphic graphic_table graphicRef53246" href="/z/d/graphic/53246.html" rel="external">table 1</a>). The questions, below, were originally validated primarily in male veterans, but now have demonstrated validity in primary care and other populations [<a href="#rid22">22,23</a>]. The AUDIT-C is briefer than the original test, but still requires scoring. (See <a class="local">'AUDIT'</a> below.)</p><p class="bulletIndent1"><span class="glyph">●</span>How often do you have a drink containing alcohol?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>How many drinks containing alcohol do you have on a typical day when you are drinking?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>How often do you have six or more drinks on one occasion?</p><p></p><p>Scores considered positive for unhealthy drinking are [<a href="#rid24">24</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Three or more in women, with 73 percent sensitivity and 91 percent specificity</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Four or more in men, with 86 percent sensitivity and 89 percent specificity</p><p></p><p>Although the AUDIT-C contains no items specific to disorders, the score is associated with severity; a score of 7 to 10 or greater suggests DSM-5-TR alcohol use disorder [<a href="#rid25">25</a>]. As with the full AUDIT, it is best to alter the third question by replacing “six” with “four” when used in women, if feasible [<a href="#rid26">26</a>].</p><p class="headingAnchor" id="H521965"><span class="h3">AUDIT</span><span class="headingEndMark"> — </span>The AUDIT is the most widely validated instrument  (<a class="graphic graphic_figure graphicRef72626" href="/z/d/graphic/72626.html" rel="external">figure 1</a>). With 10 items, which take two to three minutes to complete, the AUDIT is not brief and does require scoring [<a href="#rid27">27,28</a>]. As a result, it is better suited to settings where visit times are longer or when it can be completed prior to a clinician visit and electronically scored.</p><p>The instrument and calculator shown here will determine the respondent’s score on the AUDIT after completion (<a class="calc calc_patient" href="/z/d/html/13435.html" rel="external">calculator 1</a>).</p><p>With a score that can range from 0 to 40, a score of 8 or greater on the AUDIT is generally considered a positive test for unhealthy alcohol use, with greater than 90 percent sensitivity and 80 percent specificity [<a href="#rid28">28-30</a>]. Studies specifically focused on primary care settings in the United States suggest using lower scores (eg, four to seven) as positive for optimal sensitivity given the low cost and consequences of false positives [<a href="#rid24">24</a>]. We find it most useful to alter the number of drinks (particularly in the third question) to “5 or more” to account for United States drink sizes and to “4 or more” for administration to women, and using a cutoff of 5 for men and 3 for women (the traditional cutoff widely published is 8 or greater) [<a href="#rid24">24,28,31</a>]. A score of 20 or greater suggests the presence of alcohol dependence. The AUDIT was used in a large multisite international randomized trial of brief intervention in primary care [<a href="#rid32">32</a>].</p><p class="headingAnchor" id="H1272522"><span class="h3">CAGE questions</span><span class="headingEndMark"> — </span>The four CAGE alcohol screening questions are geared towards detection of a substance use disorder. The questions are not sensitive for detecting the full spectrum of unhealthy use [<a href="#rid30">30,33,34</a>]. The CAGE is not recommended as a screening tool, but it can be useful for quickly finding out if someone who screens positive on a single-item screening question has or has had a more severe problem (by answering two or more in the affirmative). The CAGE questions are:</p><p class="bulletIndent1"><span class="glyph">●</span>Have you ever felt you should <strong>Cut down</strong> on your drinking?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have people <strong>Annoyed </strong>you by criticizing your drinking?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have you ever felt bad or <strong>Guilty </strong>about your drinking?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have you ever taken a drink first thing in the morning (<strong>Eye-opener</strong>) to steady your nerves or get rid of a hangover?</p><p></p><p>Two affirmative responses are 77 percent sensitive and 79 percent specific for alcohol use disorder, but only 53 percent and 70 percent, respectively, for unhealthy alcohol use [<a href="#rid30">30</a>].</p><p>If CAGE questions are used for screening, a single affirmative response should be considered a positive test. The CAGE should be supplemented with consumption items that identify risky amounts [<a href="#rid34">34</a>]. These additions increase the number of screening items to seven with little advantage over the AUDIT-C (though advantages include the facts that scoring is not needed, and that responses to CAGE questions provide content for discussion of consequences during brief counseling).</p><p class="headingAnchor" id="H1272541"><span class="h3">Special populations</span><span class="headingEndMark"> — </span>Screening tools have been validated for certain sub-populations (ie, women, pregnant women, older adults, adolescents). For women and older adults, their test operating characteristics do not likely differ sufficiently from the AUDIT, AUDIT-C, or single-item questions to warrant introducing the complexity of implementing different instruments. In the cases of pregnancy and adolescents, different tools are warranted.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Older</strong> <strong>adults</strong> – The Comorbidity Alcohol Risk Evaluation Tool (CARET) assesses consumption, comorbidities, and medication use to identify older adults at risk for alcohol consequences [<a href="#rid35">35</a>]. The geriatric version of the Michigan Alcoholism Screening Test (G-MAST) primarily detects alcohol use disorders [<a href="#rid36">36,37</a>]. For practical reasons (eg, the difficulty of using multiple different tests for screening) these tests are most appropriate for practices comprised exclusively of elders.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pregnancy</strong> – In pregnancy and peri-conception, the goal of screening is to detect any drinking, but because drinking in pregnancy may be a sensitive issue (pregnant women often feel guilty about drinking), several screening tests have been developed and validated for this circumstance, including the TWEAK, T-ACE, 4Ps Plus, and the NET [<a href="#rid38">38-40</a>]. Use of AUDIT-C and the CAGE has also been studied in pregnancy, and all approaches should add or include an item about any drinking (see below).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The T-ACE questions can be useful in circumstances where the practice determines it is feasible to use a multi-item questionnaire specifically for pregnant women. The T-ACE questions, below, are adapted from the CAGE [<a href="#rid38">38</a>] yet despite this they are sensitive for detecting risky drinking amounts. An affirmative response to any item is considered a positive test.</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Tolerance – How many drinks does it take to make you feel high? (&gt;2 drinks is an affirmative response)</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Annoyed, Cut down, Eye opener (See <a class="local">'CAGE questions'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If the practice wishes to use a brief multi-item questionnaire that includes other drugs, the 4Ps Plus is the best choice. (See <a class="local">'Pregnancy'</a> below.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>AUDIT-C is recommended if it is already being used by the practice for other populations, which reduces aforementioned sensitivity concerns regarding asking about drinking directly, because all patients are being asked. The advantage is that it is best at detecting the whole spectrum of unhealthy use and includes an item that identifies any drinking. (See <a class="local">'AUDIT-C'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>If a clinician finds a multi-item questionnaire excessively burdensome, it may make sense to ask all pregnant women “Do you sometimes drink beer, wine or other alcoholic beverages?” to identify any use. Research studies have not yet assessed the value of this approach, yet since the behavior of interest is any consumption, asking all women this question is reasonable even if a validated multi-item tool is being used to identify risky drinking.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adolescents</strong> – NIAAA recommends two questions for youth age 14 to 18, below [<a href="#rid41">41</a>]. Results that indicate any days drinking and any friends drinking more than three to four drinks (two for females) in a day suggest the need for further discussion and advice.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>“In the <strong>past year</strong>, <strong>on how many days </strong>have you had more than a few sips of beer, wine, or any drink containing alcohol” </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>“If your friends drink, <strong>how many drinks </strong>do they usually drink on an occasion.”</p><p></p><p class="bulletIndent1">A single screening question, “In the past year, how many times have you used alcohol?” has been developed for self- or interviewer-administration [<a href="#rid42">42</a>]. A positive screen is a response of “once or twice” (or more) versus “none.” A cross-sectional study among 213 adolescents (age 12 to 17) in several adolescent practices found the question to be sensitive and specific for alcohol use disorder (cutoff of monthly, 79 and 96 percent, respectively) and for severe alcohol use disorder (cutoff weekly or greater [almost daily or daily], 100 and 88 percent, respectively).</p><p></p><p class="bulletIndent1">The CRAFFT instrument is the best validated tool to screen for substance use disorders in adolescents [<a href="#rid43">43-45</a>]. However, its use may be best reserved for assessing risk level because the target of screening in youth should be any use, not specific amounts or disorders [<a href="#rid46">46</a>], so the questions above asking about any use over the past year makes sense. CRAFFT is an acronym for Car, Relax, Alone, Forget, Friends, Trouble. (See  <a class="medical medical_review" href="/z/d/html/2872.html" rel="external">"Screening tests in children and adolescents", section on 'Nicotine, alcohol, and substance use'</a>.)</p><p></p><p class="headingAnchor" id="H1272756"><span class="h3">Laboratory testing</span><span class="headingEndMark"> — </span>In general, laboratory testing, which can establish recent use or heavy use, adds additional cost and is not useful for screening for unhealthy use. While not ideal, however, if a practice cannot or does not implement routine universal screening with questionnaires, then testing for serum carbohydrate deficient transferrin can detect very heavy drinking. This laboratory test option would be better than no screening, and in fact when added to questionnaires it can detect heavy use among some who are negative by questionnaire and is cost effective [<a href="#rid47">47</a>]. However, the patient should be informed of testing, which can be awkward since it means telling a patient who denies heavy drinking that they will be tested for heavy drinking. (See  <a class="medical medical_review" href="/z/d/html/7809.html" rel="external">"Risky drinking and alcohol use disorder: Epidemiology, clinical features, adverse consequences, screening, and assessment"</a>.)</p><p>One rationale for laboratory testing is to have a result that can be repeated in follow-up to motivate the patient and confirm progress. A test can be useful for this purpose as long as it is elevated to begin with (which is often not the case in people who screen positive by questionnaire).</p><p>Laboratory testing can be helpful when a patient is critically injured or cannot speak. In such circumstances, patients may not be truthful, recall their consumption, or be able to be interviewed at the time of their injury. A blood or breath alcohol level that indicates use or levels consistent with intoxication can be useful information supplementing questionnaires that can be done later.</p><p class="headingAnchor" id="H2788961"><span class="h2">Unhealthy use of other drugs</span><span class="headingEndMark"> — </span>Drug screening is more difficult than screening for unhealthy alcohol use. One challenge is that screening tools need to target a range of drugs, including prescription drugs, not simply one substance. Another challenge is that amounts that risk health consequences are not well-defined and differ across addictive drugs. (See <a class="local">'Other drugs'</a> above.)</p><p>We suggest use of a single question to screen for drug use rather than other brief screening tests, few of which have been well-validated in primary care settings.</p><p class="headingAnchor" id="H3579420"><span class="h3">Single-item screening</span><span class="headingEndMark"> — </span>A single-item screening test is just as well validated in primary care settings as longer questionnaires. It has similar sensitivity and specificity for any drug use, drug use with consequences, and drug use disorders as the 10-item Drug Abuse Screening Test (DAST) [<a href="#rid18">18</a>]. A response of greater than 0 is a positive test and is 100 percent sensitive and 74 percent specific for a drug use disorder, and 93 percent and 94 percent, respectively, for past-year drug use.</p><p>The screening question is:</p><p class="bulletIndent1"><span class="glyph">●</span>“How many times in the past year have you used an illegal drug or used a prescription medication for nonmedical reasons?” </p><p></p><p>If asked to clarify the meaning of “nonmedical reasons,” add "for instance because of the experience or feeling it caused.”</p><p>In a two-site cross sectional study of 459 adult primary care patients, the item was similarly accurate when self-administered on touchscreen tablet computers [<a href="#rid21">21</a>].</p><p>A single screening question, “In the past year, how many times have you used alcohol?” described above for alcohol screening, has also been applied to cannabis, illegal drugs, prescription drugs that were not prescribed, over-the-counter medication, inhalants, and herbs or synthetic drugs. Sensitivity and specificity for nontobacco substance use was 100 and 84 percent, respectively. (See <a class="local">'Special populations'</a> above.)</p><p>Because cannabis is now more widely legal, and because <a class="drug drug_general" data-topicid="134930" href="/z/d/drug information/134930.html" rel="external">medical cannabis</a> is often not prescribed (patients are certified and doses and frequencies are not usually specified by clinicians), single screening questions may miss recreational use or use beyond that recommended by a clinician. One solution is to remove the word “illegal” from the single item. Another is to add a question about frequency of cannabis use (eg “How many times in the past year have you used marijuana?”). Although a positive response may not mean high risk use, use can be further assessed, and it remains relevant for clinicians to be aware of its use.</p><p class="headingAnchor" id="H25165350"><span class="h3">DAST</span><span class="headingEndMark"> — </span>The Drug Abuse Screening Test (DAST) was developed in addiction treatment rather than primary care settings [<a href="#rid18">18,48</a>]. A score of 3 or more on this questionnaire with 10 yes/no items suggests drug use with adverse consequences. As such, it may have some utility for assessing severity.</p><p class="headingAnchor" id="H3874087998"><span class="h3">Screen of drug use</span><span class="headingEndMark"> — </span>The screen of drug use is a misnomer, as it was validated in a cross-sectional study of 1283 veterans in primary care to detect drug use disorders, not use (92 percent sensitive and 93 percent specific). The two items are, “How many days in the past 12 months have you used drugs other than alcohol?” (positive if 7 or more and skip the next item) and “How many days in the past 12 months have you used drugs more than you meant to?” (positive if 2 or more) [<a href="#rid49">49</a>]. Good sensitivities and specificities were found for cannabis use disorder (100 and 87.5 percent) [<a href="#rid50">50</a>], opioid use disorder (100 and 86.3 percent) [<a href="#rid51">51</a>], and stimulant use disorder (93.7 and 89.1 percent) [<a href="#rid52">52</a>].</p><p class="headingAnchor" id="H25165357"><span class="h3">ASSIST</span><span class="headingEndMark"> — </span>The length of the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2F978924159938-2&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h7bLDDnWC3XicBcpsIGU3t1RpwPFBj2iTDhKz9Qn7gvOQ%3D%3D&amp;TOPIC_ID=14843" target="_blank">Alcohol, Smoking and Substance Involvement Screening Test</a> (ASSIST; 8 questions each referring to up to 10 substances) precludes its broad use, but one advantage is that it provides additional information useful for assessment and discussion during brief intervention [<a href="#rid53">53</a>]. Computerized administration and scoring can lessen the time needed to use the instrument.</p><p>A score of 4 or greater on any other drug on the ASSIST indicates moderate to high risk use. A lower nonzero score indicates recent or past use. A substance-specific score of 27 or greater may indicate a substance use disorder.</p><p class="headingAnchor" id="H25165382"><span class="h3">Laboratory testing</span><span class="headingEndMark"> — </span>Laboratory testing is not particularly useful for screening populations for other drug use because routine tests generally detect only recent use. Outside the screening context, urine drug tests can be useful for assessing risk and monitoring patients with chronic pain treated with opioids, or as part of a diagnostic work-up of symptoms that may indicate drug use.</p><p>Drug detection depends in part on the half-life of the drug, distribution of the drug, and chronicity of use. Testing has not been well studied in a general preventive healthcare context that relies on trust and a collaborative relationship between patient and clinician. The clinician needs to inform the patient of the testing and its purpose, which means a discussion must occur, during which time one could simply ask screening questions instead. If the patient is informed testing will be done, it could increase the validity of the self-report questionnaire but introduce an element of mistrust.</p><p>Testing is further complicated by the need to test for a wide range of drugs and does not distinguish between appropriate and inappropriate use of prescription drugs. Routine serum and urine test panels often include opiates, cocaine, amphetamines, benzodiazepines, barbiturates, <a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">acetaminophen</a>, alcohol, and <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>. Opioids other than <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a> and <a class="drug drug_general" data-topicid="9291" href="/z/d/drug information/9291.html" rel="external">codeine</a> (eg, <a class="drug drug_general" data-topicid="9623" href="/z/d/drug information/9623.html" rel="external">methadone</a>, <a class="drug drug_general" data-topicid="9170" href="/z/d/drug information/9170.html" rel="external">buprenorphine</a>, <a class="drug drug_general" data-topicid="9729" href="/z/d/drug information/9729.html" rel="external">oxycodone</a>, and <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) require specific individual tests. Possible false positives for addictive drugs require confirmation with gas chromatography-mass spectrometry.</p><p class="headingAnchor" id="H2788968"><span class="h2">Unhealthy alcohol and other drug use</span><span class="headingEndMark"> — </span>A number of screening questionnaires ask about both alcohol and other drugs. Some allow identification of unhealthy alcohol and other drug use separately, and others identify that unhealthy alcohol or other drug use is present without specifying which is present.</p><p class="bulletIndent1"><span class="glyph">●</span>If brevity and simplicity are the primary concerns, asking the separate single items for alcohol and other drug use is recommended. (See <a class="local">'Single-item screening'</a> above and <a class="local">'Single-item screening'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If computerized administration is possible or if there is more time available, the ASSIST is a reasonable choice because it can identify alcohol, tobacco and other drugs and provides a risk score for alcohol and drug use. A drawback of the ASSIST is that it does not directly identify use of risky amounts of alcohol, and it is time consuming if the patient uses many different substances. (See <a class="local">'ASSIST'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Other screening tools that ask about both alcohol and drugs include the CAGE adapted to include drugs (CAGE AID) [<a href="#rid54">54,55</a>], and a two-item “conjoint” questionnaire [<a href="#rid54">54</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The four-item Substance Use Brief Screen (SUBS) asks about tobacco, alcohol, illegal drugs, and prescription medications with three frequency response options  (<a class="graphic graphic_table graphicRef109025" href="/z/d/graphic/109025.html" rel="external">table 2</a>) [<a href="#rid56">56</a>]. For each item, a response of “never” represents a negative screen, and the other two responses represent a positive screen. The SUBS was tested in a two-site cross-sectional validation study of 586 adult primary care patients. Sensitivity was 83 to 85 percent for unhealthy use of alcohol and other drugs, and specificity was 77 to 91 percent.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The Tobacco, Alcohol, Prescription Medication, and Other Substance use (TAPS) tool was designed to detect “problem” use and disorders with an initial (the TAPS-1) four items with five response options for each [<a href="#rid57">57</a>]. Positive responses are 98 percent, 85 percent, 91 percent, and 85 percent sensitive for problem tobacco, alcohol, medication, and other drug use, respectively, and 70 to 91 percent specific in a cross-sectional study of 2000 adult primary care patients. Although designed for and tested in primary care, and with some advantages to being able to use one tool across substances, the major limitation is that the tool is not validated to identify any smoking, any illicit or nonmedical drug use, or risky amounts of alcohol.</p><p></p><p class="headingAnchor" id="H98182254"><span class="h3">Pregnancy</span><span class="headingEndMark"> — </span>The 4Ps Plus is a validated screening tool that asks about both alcohol and other drug use in pregnancy (<strong>P</strong>ast use, <strong>P</strong>regnancy, use by <strong>P</strong>arents and <strong>P</strong>artners) [<a href="#rid58">58</a>]. Items are:</p><p class="bulletIndent1"><span class="glyph">●</span>Did either of your parents ever have a problem with alcohol or drugs?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Does your partner have a problem with alcohol or drugs?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Have you ever drunk beer, wine, or liquor?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the month before you knew you were pregnant, how many cigarettes did you smoke?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the month before you knew you were pregnant how many beers/how much wine/how much liquor did you drink?</p><p></p><p>The test is positive if questions about use during or before pregnancy are affirmative. (See <a class="local">'Special populations'</a> above.)</p><p class="headingAnchor" id="H520037"><span class="h1">FREQUENCY</span><span class="headingEndMark"> — </span>Although there is little evidence upon which to base a recommendation of screening frequency, federally-funded screening programs and the Department of Veterans Affairs recommend annual screening. The rationale is based on convenience (the assumption of an annual examination attending to preventive services) and an expectation that a year is sufficient time for health habits to change. Preliminary studies seem to support this with a 3 to 6 percent incidence of unhealthy alcohol use over one to three years [<a href="#rid59">59,60</a>].</p><p class="headingAnchor" id="H27417920"><span class="h1">IMPLEMENTATION</span><span class="headingEndMark"> — </span>Although screening with brief questionnaires is feasible in real world practice settings, and significant initiatives have been undertaken, some early efforts at implementation failed to show large benefits. As examples:</p><p class="bulletIndent1"><span class="glyph">●</span>A randomized trial of implementing alcohol screening in 77 general medical practices in the Netherlands involved training, feedback, outreach visits, patient materials, and guideline dissemination, but did not result in improvement to practice screening rates, which remained at approximately 10 percent [<a href="#rid61">61</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A survey of 746 clinicians in Europe who agreed to participate in an implementation study of alcohol screening and brief intervention reported screening rates between 2 and 10 percent of patients [<a href="#rid62">62</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the United Kingdom, an implementation study found no benefit of alcohol screening and brief intervention in primary care. All were screened, then patients were randomized to receive an informational pamphlet or one of two brief interventions) [<a href="#rid63">63</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An initiative to implement near-universal alcohol screening in United States Veterans' hospitals and clinics using the Alcohol Use Disorders Identification Test (AUDIT)-C showed that when staff administered the screen, they sometimes did not ask the questions verbatim, resulting in poor quality screening. A minority of those screening positive received a brief intervention, and those who received the brief intervention did not show greater resolution of unhealthy alcohol use compared with those who did not receive a brief intervention, although those who received the intervention had more severe health problems at baseline. [<a href="#rid64">64,65</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A randomized implementation trial in 54 adult primary care clinics within a large United States private integrated health system found that screening rates were highest when done by nonphysicians and medical assistants compared with primary care physicians (51 versus 9 percent). Screening by nonphysicians rarely resulted in brief interventions among those who screened positive and was much lower in comparison to physicians (3 versus 44 percent) [<a href="#rid66">66</a>].</p><p></p><p>However, later work shows considerable promise for implementation of systematic screening for unhealthy alcohol use:</p><p class="bulletIndent1"><span class="glyph">●</span>In an implementation feasibility study in six urban primary care clinics that used both single-item screening and AUDIT-C of 93,114 eligible patients, 71.8 percent received alcohol screening. Screening at any visit versus only at annual visits was associated with higher screening rates. Importantly, clinics that used a patient self-administered screen detected higher rates of moderate to high-risk alcohol use (14.7 to 36.6 percent) compared with the clinic that used staff-administered screening (1.6 percent) [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a stepped-wedge cluster randomized implementation trial, including 22 primary care practices in an integrated health system in Washington state with implementation providing practice facilitation, electronic health record (EHR) decision support, and performance feedback, among 333,596 patients, alcohol screening rates after implementation were 83.2 percent compared with 20.8 percent pre-implementation. More patients received brief intervention during the implementation phase than during pre-implementation (57 versus 11 percent). Among patients with diagnosed alcohol use disorder treatment initiation was slightly higher during implementation, but treatment engagement did not differ between implementation and pre-implementation [<a href="#rid68">68</a>].</p><p></p><p>Implementation of screening for drug use has encountered more challenges than has screening for alcohol use:</p><p class="bulletIndent1"><span class="glyph">●</span>In the implementation feasibility study in six urban primary care clinics described above, a positive single-item screen for drugs was followed by completion of the Drug Abuse Screening Test (DAST). Among 93,114 eligible patients, 70.5 percent received screening for drug use, but only 0.3 to 1.0 percent screened positive for moderate- to high-risk drug use suggesting that screening in real life primary care settings does not detect drug use effectively [<a href="#rid67">67</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a substudy to the implementation feasibility study mentioned just above using similar methodology in a rural primary care clinic among 3749 patients, 10.8 percent screened positive for cannabis (in a cannabis-legal state), 0.3 percent for illicit drugs, and 0.6 percent for nonmedical use of prescription drugs, again suggesting that screening does not detect drug use effectively with the possible exception of cannabis [<a href="#rid69">69</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A study in 20 primary care clinics used a pre-post design to determine the impact of screening for opioid use disorder on detection of new cases. The screening was performed using the opioid section of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) or with a new, unvalidated measure, the Short Opioid Screen, which used two simple questions about prescription opioid use and illegal opioid use. EHRs were searched to identify new cases of opioid use disorder during the six months prior to the screening implementation and in the six months post. No significant increase in identification of new cases occurred during the screening period again suggesting that current screening technique do not effectively detect opioid use disorder [<a href="#rid70">70</a>].</p><p></p><p>Thus, current evidence indicates that, with the possible exception of screening for cannabis use, better screening methods will need to be developed to detect unhealthy drug use or drug use disorders via screening in primary care settings.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>EHR</strong> <strong>support</strong> – Screening tests can be embedded into EHRs that record and score responses and display results. EHRs are capable of providing decision support that recommends, for example, further assessment and advice specific to patients based on their results [<a href="#rid71">71-74</a>]. At Veterans Affairs Medical Centers in the United States, where clinicians are required to screen all patients annually, the AUDIT-C is available and scored in the EHR [<a href="#rid71">71,75</a>]. A clinical reminder prompts the clinician to administer the screening at a patient visit.</p><p></p><p class="headingAnchor" id="H2788975"><span class="h1">ASSESSMENT AND SUBSEQUENT CARE</span><span class="headingEndMark"> — </span>Following a positive screening test that newly identifies a primary care patient with unhealthy substance use, they should receive a full substance use assessment, including the amount of alcohol consumed, medical consequences of substance use, and symptoms of substance use disorder. In some circumstances full assessment is more appropriate than screening. These include treatment settings in which the prevalence of substance use disorders is known to be very high (eg, mental health, criminal legal system).</p><p class="headingAnchor" id="H573271"><span class="h2">Drinking amounts</span><span class="headingEndMark"> — </span>Positive screening tests do not necessarily provide the information needed to evaluate the patient for risky drinking. After a positive screening test, the patient should be asked about their consumption:</p><p class="bulletIndent1"><span class="glyph">●</span>On average, how many days per week do you drink alcohol?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>On a typical day when you drink, how many drinks do you have?</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>What is the maximum number of drinks you had on any given occasion during the last month?</p><p></p><p class="headingAnchor" id="H1052718"><span class="h2">Medical consequences</span><span class="headingEndMark"> — </span>A positive screening test for unhealthy substance use should prompt review of the patient’s medical history, review of systems, and physical examination findings for possible medical risks and consequences of alcohol or drug use, as these risks can become part of a discussion of unhealthy substance use. The list of potential conditions is extensive and varies with the substance used. (See  <a class="medical medical_review" href="/z/d/html/4840.html" rel="external">"Overview of the chronic neurologic complications of alcohol"</a> and  <a class="medical medical_review" href="/z/d/html/7151.html" rel="external">"Hematologic complications of alcohol use"</a> and  <a class="medical medical_review" href="/z/d/html/3617.html" rel="external">"Clinical manifestations and diagnosis of alcohol-associated fatty liver disease and cirrhosis"</a> and  <a class="medical medical_review" href="/z/d/html/14381.html" rel="external">"Fetal alcohol spectrum disorder: Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2784.html" rel="external">"Cardiovascular benefits and risks of moderate alcohol consumption", section on 'Effect of alcohol on cardiovascular risk'</a> and  <a class="medical medical_review" href="/z/d/html/3467.html" rel="external">"Alcohol-induced cardiomyopathy"</a> and  <a class="medical medical_review" href="/z/d/html/4818.html" rel="external">"Wernicke encephalopathy"</a> and  <a class="medical medical_review" href="/z/d/html/5010.html" rel="external">"Prenatal substance exposure and neonatal abstinence syndrome (NAS): Clinical features and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/4953.html" rel="external">"Clinical manifestations, diagnosis, and management of the cardiovascular complications of cocaine abuse"</a> and  <a class="medical medical_review" href="/z/d/html/4343.html" rel="external">"Pulmonary complications of cocaine use"</a> and  <a class="medical medical_review" href="/z/d/html/4799.html" rel="external">"Substance use during pregnancy: Screening and prenatal care"</a> and  <a class="medical medical_review" href="/z/d/html/4337.html" rel="external">"Overview of pulmonary disease in people who inject drugs"</a> and  <a class="medical medical_review" href="/z/d/html/5166.html" rel="external">"Drug-induced myopathies"</a> and  <a class="medical medical_review" href="/z/d/html/8374.html" rel="external">"Drug-induced neutropenia and agranulocytosis"</a> and  <a class="medical medical_review" href="/z/d/html/1696.html" rel="external">"Leukoencephalopathy due to heroin use"</a> and  <a class="medical medical_review" href="/z/d/html/3675.html" rel="external">"Epidemiology and transmission of hepatitis C virus infection", section on 'Injection drug use'</a> and  <a class="medical medical_review" href="/z/d/html/3724.html" rel="external">"The natural history and clinical features of HIV infection in adults and adolescents"</a> and  <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">"Overview of the evaluation of stroke"</a>.)</p><p class="headingAnchor" id="H2788982"><span class="h2">Substance use disorder</span></p><p class="headingAnchor" id="H256368057"><span class="h3">Diagnosis in DSM-5-TR</span><span class="headingEndMark"> — </span>Substance use disorder, is diagnosed based on the following criteria [<a href="#rid2">2</a>]:</p><p>“A problematic pattern of substance use leading to clinically significant impairment or distress, as manifested by at least two of the following occurring within a 12-month period:</p><p class="bulletIndent1"><span class="glyph">●</span>The substance is often taken in larger amounts or over a longer period than was intended.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is a persistent desire or unsuccessful efforts to cut down or control use of the substance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A great deal of time is spent in activities necessary to obtain the substance, use the substance, or recover from its effects.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Craving, or a strong desire or urge to use the substance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent use resulting in a failure to fulfill major role obligations at work, school, or home.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Continued use despite having persistent or recurrent social or interpersonal problems caused by or exacerbated by its effects.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Important social, occupational, or recreational activities are given up or reduced because of use.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Recurrent use in situations in which it is physically hazardous.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Tolerance.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Withdrawal.</p><p></p><p>Current severity can be specified in the diagnosis based on the number of symptoms present:</p><p class="bulletIndent1"><span class="glyph">●</span>Mild: Two to three symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Moderate: Four to five symptoms</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Severe: Six or more symptoms”</p><p></p><p class="headingAnchor" id="H256368051"><span class="h3">Brief assessment strategies</span><span class="headingEndMark"> — </span>Brief assessment strategies for a substance use disorder are preferable to full diagnostic interviews in the context of screening and brief intervention due to time constraints in primary care. However, these strategies, described below, have not been studied extensively for this purpose. Related strategies can also be useful to identify the presence and severity of the substance use disorder, as well as consequences of use, which provides useful information for treatment [<a href="#rid4">4,76</a>]. The main purpose of the brief assessment is to identify consequences of use to discuss with patients and to identify moderate to severe disorders in patients for whom treatment goals are different.</p><p class="bulletIndent1"><span class="glyph">●</span>If a single question has been used for screening, then a moderate to severe substance use disorder should be identified by asking patients about DSM-5-TR symptoms. Such questions can also be useful to identify symptoms and consequences of use. Among 11,464 primary care patients who screened positive on the Alcohol Use Disorders Identification Test (AUDIT)-C and completed an Alcohol Symptom Checklist consisting of the 11 DSM-5-TR criteria, 54.1 percent reported ≥2 criteria for alcohol use disorder on the checklist (threshold for alcohol use disorder diagnosis). The checklist performed equitably across all demographic groups [<a href="#rid77">77</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a questionnaire that provides severity information has been used for screening, then that result may provide sufficient initial assessment information.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A threshold severity score for some screening instruments has been associated with a diagnosis of substance use disorder. (See <a class="local">'AUDIT'</a> above and <a class="local">'AUDIT-C'</a> above and <a class="local">'CAGE questions'</a> above and <a class="local">'ASSIST'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An affirmative response to specific questions on some screening instruments suggests the presence of a substance use disorder. An example is the “eye-opener” question on the CAGE. (See <a class="local">'CAGE questions'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Two single-item questions have been used to identify alcohol use disorder in patients with unhealthy alcohol use, with a sensitivity ranging from 77 to 95 percent and specificity from 62 to 86 percent [<a href="#rid78">78</a>]. The two items are:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the past year, have you sometimes been under the influence of alcohol in situations where you could have caused an accident or gotten hurt?</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Have there often been times when you had a lot more to drink than you intended to have?</p><p></p><p>A question about prior treatment for a substance use disorder (SUD) can provide a quick entry point into the treatment of an ongoing or recurrent disorder.</p><p class="headingAnchor" id="H256368076"><span class="h3">Implications of screening for brief intervention</span><span class="headingEndMark"> — </span>The presence of a substance use disorder has implications for subsequent care. A brief intervention for a patient in primary care with unhealthy substance use, including a <strong>mild</strong> substance use disorder, would be aimed at abstinence or reduced substance use. The optimal goal of brief intervention in primary care for a patient diagnosed with a <strong>moderate to severe</strong> substance use disorder would be for the patient to enter and participate in SUD treatment often in specialty care, though SUD treatment, particularly pharmacotherapy, is increasingly being offered directly in primary care [<a href="#rid79">79,80</a>]. Patients at risk for withdrawal (patients with physical dependence or consumption of current daily risky amounts) would first undergo medically supervised withdrawal. (See  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration"</a> and  <a class="medical medical_review" href="/z/d/html/323.html" rel="external">"Management of moderate and severe alcohol withdrawal syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/7810.html" rel="external">"Alcohol use disorder: Psychosocial management"</a> and  <a class="medical medical_review" href="/z/d/html/7803.html" rel="external">"Opioid use disorder: Pharmacologic management"</a> and  <a class="medical medical_review" href="/z/d/html/106878.html" rel="external">"Stimulant use disorder: Treatment overview"</a> and  <a class="medical medical_review" href="/z/d/html/16750.html" rel="external">"Stimulant use disorder: Psychosocial management"</a>.)</p><p class="headingAnchor" id="H2269029662"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/113803.html" rel="external">"Society guideline links: Insomnia in adults"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/113643.html" rel="external">"Society guideline links: Opioid use disorder and withdrawal"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/114814.html" rel="external">"Society guideline links: Benzodiazepine use disorder and withdrawal"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/114306.html" rel="external">"Society guideline links: Alcohol use disorders and withdrawal"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/115010.html" rel="external">"Society guideline links: Stimulant use disorder and withdrawal"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/114308.html" rel="external">"Society guideline links: Cannabis use disorder and withdrawal"</a>.)</p><p class="headingAnchor" id="H2654873"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unhealthy alcohol use</strong> – Amounts of alcohol that increase health risks have been estimated in terms of a “standard drink” (approximately 12 grams of ethanol, 5 ounces of wine, 12 ounces of beer, or 1.5 ounces of 80 proof spirits) (see <a class="local">'Unhealthy alcohol or drug use'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For men under age 65, unhealthy use is more than 14 standard drinks per week or more than four drinks on any day</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For women and older adults, unhealthy use is more than seven standard drinks per week or more than three drinks on any day</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for screening</strong> – We recommend that all adult primary care patients be screened for unhealthy alcohol use (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). In general, annual screening is suggested. (See <a class="local">'Indications'</a> above and <a class="local">'Frequency'</a> above and  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Screening tests</strong> – We suggest use of the single-item alcohol screening question for most primary care practices and use of the AUDIT-C, which provides additional information useful to treatment, by practices with more resources (eg, staff, time, or the capacity to automate administration and scoring)  (<a class="graphic graphic_table graphicRef53246" href="/z/d/graphic/53246.html" rel="external">table 1</a>) (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Single-item screening'</a> above and <a class="local">'AUDIT-C'</a> above.)</p><p></p><p class="bulletIndent1">There is some indication that screening for unhealthy alcohol use by self-report leads to better detection than does staff-administered screening.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Further assessment</strong> – A patient who receives a positive screen should be assessed for a moderate to severe substance use disorder and for medical and other consequences of use. (See <a class="local">'Assessment and subsequent care'</a> above and  <a class="medical medical_review" href="/z/d/html/7810.html" rel="external">"Alcohol use disorder: Psychosocial management"</a> and  <a class="medical medical_review" href="/z/d/html/7802.html" rel="external">"Cocaine use disorder: Epidemiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7803.html" rel="external">"Opioid use disorder: Pharmacologic management"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Subsequent care</strong> – Brief intervention is the standard treatment for adult patients in primary care who are identified through screening to have unhealthy alcohol use, including those with a <strong>mild </strong>substance use disorder. The brief intervention would be aimed at abstinence or reduced substance use. The optimal goal of brief intervention in primary care for a patient diagnosed with a <strong>moderate to severe</strong> substance use disorder would be for the patient to receive more extensive substance use disorder treatment. (See <a class="local">'Substance use disorder'</a> above and  <a class="medical medical_review" href="/z/d/html/14832.html" rel="external">"Brief intervention for unhealthy alcohol and other drug use: Efficacy, adverse effects, and administration"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unhealthy use of other drugs</strong> – For all adult primary care patients, we screen for unhealthy use of drugs other than alcohol when services are in place to ensure follow-up for diagnosis and treatment. However, it should be recognized that methods so far developed for screening for drug use in real world primary care settings fail to detect many cases of use or of substance use disorder. (See <a class="local">'Indications'</a> above and <a class="local">'Unhealthy use of other drugs'</a> above and <a class="local">'Substance use disorder'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A single-item screening, with an additional question about cannabis use, is a reasonable choice for most practices when patients are screened for other drugs.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The Substance Use Brief Screen is a reasonable choice to screen for tobacco, alcohol, and other drugs using only four questions  (<a class="graphic graphic_table graphicRef109025" href="/z/d/graphic/109025.html" rel="external">table 2</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For practices with additional resources, screening with the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.who.int%2Fpublications%2Fi%2Fitem%2F978924159938-2&amp;token=mr3MkQMxxRm373pPGLTYB%2B8L7rJeOJtqYOfpSLq18h7bLDDnWC3XicBcpsIGU3t1RpwPFBj2iTDhKz9Qn7gvOQ%3D%3D&amp;TOPIC_ID=14843" target="_blank">Alcohol, Smoking and Substance Involvement Screening Test (ASSIST)</a> can provide additional information that is useful for treatment.</p><p></p><p class="headingAnchor" id="H3602741278"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Richard Saitz, MD, MPH, FACP, DFASAM (deceased), who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA 2004; 291:1238.</a></li><li class="breakAll">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, text revision (DSM-5-TR), American Psychiatric Association, 2022.</li><li><a class="nounderline abstract_t">U.S. Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement. Ann Intern Med 2004; 140:554.</a></li><li class="breakAll">National Institute on Alcohol Abuse and Alcoholism. Helping Patients Who Drink Too Much: A Clinician's Guide: Updated 2005 Edition. National Institutes of Health, Bethesda, MD 2007.</li><li><a class="nounderline abstract_t">Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med 2005; 352:596.</a></li><li class="breakAll">SAMHSA, Center for Behavioral Health Statistics and Quality. National Survey on Drug Use and Health. Department of Health and Human Services, 2022.</li><li><a class="nounderline abstract_t">Grant BF, Chou SP, Saha TD, et al. Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. JAMA Psychiatry 2017; 74:911.</a></li><li><a class="nounderline abstract_t">Rossow I, Romelsjö A. The extent of the 'prevention paradox' in alcohol problems as a function of population drinking patterns. Addiction 2006; 101:84.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Curry SJ, Krist AH, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA 2018; 320:1899.</a></li><li><a class="nounderline abstract_t">US Preventive Services Task Force, Krist AH, Davidson KW, et al. Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement. JAMA 2020; 323:2301.</a></li><li><a class="nounderline abstract_t">Patnode CD, Perdue LA, Rushkin M, et al. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2020; 323:2310.</a></li><li><a class="nounderline abstract_t">Saitz R. Screening for Unhealthy Drug Use: Neither an Unreasonable Idea Nor an Evidence-Based Practice. JAMA 2020; 323:2263.</a></li><li><a class="nounderline abstract_t">Bradley KA, Lapham GT, Lee AK. Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation. JAMA Intern Med 2020; 180:1050.</a></li><li><a class="nounderline abstract_t">Wittchen HU. Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review. J Psychiatr Res 1994; 28:57.</a></li><li class="breakAll">Sobell LC, Sobell MB, Litten RZ, Allen JP. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In: Measuring Alcohol Consumption: Psychosocial and Biochemical Methods, Litten RZ, Allen JP (Eds), Humana Press, Totowa, NJ 1992. p.41.</li><li><a class="nounderline abstract_t">Taj N, Devera-Sales A, Vinson DC. Screening for problem drinking: does a single question work? J Fam Pract 1998; 46:328.</a></li><li><a class="nounderline abstract_t">Canagasaby A, Vinson DC. Screening for hazardous or harmful drinking using one or two quantity-frequency questions. Alcohol Alcohol 2005; 40:208.</a></li><li><a class="nounderline abstract_t">Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. A single-question screening test for drug use in primary care. Arch Intern Med 2010; 170:1155.</a></li><li><a class="nounderline abstract_t">Smith PC, Schmidt SM, Allensworth-Davies D, Saitz R. Primary care validation of a single-question alcohol screening test. J Gen Intern Med 2009; 24:783.</a></li><li><a class="nounderline abstract_t">Dawson DA, Compton WM, Grant BF. Frequency of 5+/4+ drinks as a screener for drug use and drug-use disorders. J Stud Alcohol Drugs 2010; 71:751.</a></li><li><a class="nounderline abstract_t">McNeely J, Cleland CM, Strauss SM, et al. Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients. J Gen Intern Med 2015; 30:1757.</a></li><li><a class="nounderline abstract_t">Jack HE, Oliver MM, Berger DB, et al. Association between clinical measures of unhealthy alcohol use and subsequent year hospital admissions in a primary care population. Drug Alcohol Depend 2023; 245:109821.</a></li><li><a class="nounderline abstract_t">Brummer J, Bloomfield K, Karriker-Jaffe KJ, et al. Using the alcohol use disorders identification test to predict hospital admission for alcohol-related conditions in the Danish general population: a record-linkage study. Addiction 2023; 118:86.</a></li><li><a class="nounderline abstract_t">Bradley KA, DeBenedetti AF, Volk RJ, et al. AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res 2007; 31:1208.</a></li><li><a class="nounderline abstract_t">Rubinsky AD, Kivlahan DR, Volk RJ, et al. Estimating risk of alcohol dependence using alcohol screening scores. Drug Alcohol Depend 2010; 108:29.</a></li><li><a class="nounderline abstract_t">Bradley KA, Bush KR, Epler AJ, et al. Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population. Arch Intern Med 2003; 163:821.</a></li><li><a class="nounderline abstract_t">Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction 1993; 88:791.</a></li><li class="breakAll">Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG. AUDIT: The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Health Care. 2001.</li><li><a class="nounderline abstract_t">Fiellin DA, Reid MC, O'Connor PG. Screening for alcohol problems in primary care: a systematic review. Arch Intern Med 2000; 160:1977.</a></li><li><a class="nounderline abstract_t">Maisto SA, Saitz R. Alcohol use disorders: screening and diagnosis. Am J Addict 2003; 12 Suppl 1:S12.</a></li><li><a class="nounderline abstract_t">Johnson JA, Lee A, Vinson D, Seale JP. Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study. Alcohol Clin Exp Res 2013; 37 Suppl 1:E253.</a></li><li><a class="nounderline abstract_t">Babor TF, Grant M, Acuda W, et al. A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction 1994; 89:657.</a></li><li><a class="nounderline abstract_t">Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry 1974; 131:1121.</a></li><li class="breakAll">National Institute on Alcohol Abuse and Alcoholism. Helping Patients with Alcohol Problems. A Health Practitioner's Guide. Publication No. 03–3769, National Institute of Health, 2003.</li><li><a class="nounderline abstract_t">Barnes AJ, Moore AA, Xu H, et al. Prevalence and correlates of at-risk drinking among older adults: the project SHARE study. J Gen Intern Med 2010; 25:840.</a></li><li><a class="nounderline abstract_t">Widlitz M, Marin DB. Substance abuse in older adults. An overview. Geriatrics 2002; 57:29.</a></li><li><a class="nounderline abstract_t">Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med 2014; 30:629.</a></li><li><a class="nounderline abstract_t">Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol 1989; 160:863.</a></li><li><a class="nounderline abstract_t">Russell M, Martier SS, Sokol RJ, et al. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health 1996; 86:1435.</a></li><li><a class="nounderline abstract_t">Burns E, Gray R, Smith LA. Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review. Addiction 2010; 105:601.</a></li><li class="breakAll">National Institute on Alcohol Abuse and Alcoholism. Alcohol screening and brief intervention for youth. A practitioner’s guide. NIH Publication No. 11-7805, 2011 www.niaaa.nih.gov/youthguide (Accessed on October 20, 2011).</li><li><a class="nounderline abstract_t">Levy S, Weiss R, Sherritt L, et al. An electronic screen for triaging adolescent substance use by risk levels. JAMA Pediatr 2014; 168:822.</a></li><li><a class="nounderline abstract_t">Knight JR, Sherritt L, Harris SK, et al. Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT. Alcohol Clin Exp Res 2003; 27:67.</a></li><li><a class="nounderline abstract_t">Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med 2002; 156:607.</a></li><li><a class="nounderline abstract_t">Knight JR, Shrier LA, Bravender TD, et al. A new brief screen for adolescent substance abuse. Arch Pediatr Adolesc Med 1999; 153:591.</a></li><li><a class="nounderline abstract_t">Saitz R, Naimi TS. Adolescent alcohol use and violence: are brief interventions the answer? JAMA 2010; 304:575.</a></li><li><a class="nounderline abstract_t">Kapoor A, Kraemer KL, Smith KJ, et al. Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model. Alcohol Clin Exp Res 2009; 33:1440.</a></li><li><a class="nounderline abstract_t">Skinner HA. The drug abuse screening test. Addict Behav 1982; 7:363.</a></li><li><a class="nounderline abstract_t">Tiet QQ, Leyva YE, Moos RH, et al. Screen of Drug Use: Diagnostic Accuracy of a New Brief Tool for Primary Care. JAMA Intern Med 2015; 175:1371.</a></li><li><a class="nounderline abstract_t">Tiet QQ, Leyva YE, Browne K, Moos RH. Screen of drug use: Diagnostic accuracy for cannabis use disorder. Addict Behav 2019; 95:184.</a></li><li><a class="nounderline abstract_t">Tiet QQ, Leyva YE, Moos RH. Screen of drug use: Diagnostic accuracy for opioid use disorder. Drug Alcohol Depend 2019; 198:176.</a></li><li><a class="nounderline abstract_t">Tiet QQ, Moos RH. Screen of drug use: Diagnostic accuracy for stimulant use disorder. Addict Behav 2021; 112:106614.</a></li><li><a class="nounderline abstract_t">Humeniuk R, Ali R, Babor TF, et al. Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST). Addiction 2008; 103:1039.</a></li><li><a class="nounderline abstract_t">Brown RL, Leonard T, Saunders LA, Papasouliotis O. A two-item conjoint screen for alcohol and other drug problems. J Am Board Fam Pract 2001; 14:95.</a></li><li><a class="nounderline abstract_t">Brown RL, Rounds LA. Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice. Wis Med J 1995; 94:135.</a></li><li><a class="nounderline abstract_t">McNeely J, Strauss SM, Saitz R, et al. A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS). Am J Med 2015; 128:784.e9.</a></li><li><a class="nounderline abstract_t">Gryczynski J, McNeely J, Wu LT, et al. Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care. J Gen Intern Med 2017; 32:990.</a></li><li><a class="nounderline abstract_t">Chasnoff IJ, Wells AM, McGourty RF, Bailey LK. Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus. J Perinatol 2007; 27:744.</a></li><li><a class="nounderline abstract_t">Larson MJ, Mohr MS, Brolin M, et al. High incidence of unhealthy alcohol use in older adult. Substance Abuse 2011; 32:50.</a></li><li><a class="nounderline abstract_t">Alford DP, Almeida AB, Saitz R, et al. Should adults who screen negative for unhealthy substance use be rescreened annually? J Gen Intern Med 2009; 24:S169.</a></li><li><a class="nounderline abstract_t">van Beurden I, Anderson P, Akkermans RP, et al. Involvement of general practitioners in managing alcohol problems: a randomized controlled trial of a tailored improvement programme. Addiction 2012; 107:1601.</a></li><li><a class="nounderline abstract_t">Bendtsen P, Anderson P, Wojnar M, et al. Professional's Attitudes Do Not Influence Screening and Brief Interventions Rates for Hazardous and Harmful Drinkers: Results from ODHIN Study. Alcohol Alcohol 2015; 50:430.</a></li><li><a class="nounderline abstract_t">Kaner E, Bland M, Cassidy P, et al. Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial. BMJ 2013; 346:e8501.</a></li><li><a class="nounderline abstract_t">Williams EC, Achtmeyer CE, Thomas RM, et al. Factors Underlying Quality Problems with Alcohol Screening Prompted by a Clinical Reminder in Primary Care: A Multi-site Qualitative Study. J Gen Intern Med 2015; 30:1125.</a></li><li><a class="nounderline abstract_t">Williams EC, Rubinsky AD, Chavez LJ, et al. An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration. Addiction 2014; 109:1472.</a></li><li><a class="nounderline abstract_t">Mertens JR, Chi FW, Weisner CM, et al. Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial. Addict Sci Clin Pract 2015; 10:26.</a></li><li><a class="nounderline abstract_t">McNeely J, Adam A, Rotrosen J, et al. Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics. JAMA Netw Open 2021; 4:e2110721.</a></li><li><a class="nounderline abstract_t">Lee AK, Bobb JF, Richards JE, et al. Integrating Alcohol-Related Prevention and Treatment Into Primary Care: A Cluster Randomized Implementation Trial. JAMA Intern Med 2023; 183:319.</a></li><li><a class="nounderline abstract_t">McNeely J, McLeman B, Gardner T, et al. Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients. Addict Sci Clin Pract 2023; 18:56.</a></li><li><a class="nounderline abstract_t">Fortney JC, Ratzliff AD, Blanchard BE, et al. Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis? Ann Intern Med 2023; 176:1431.</a></li><li><a class="nounderline abstract_t">Bradley KA, Williams EC, Achtmeyer CE, et al. Implementation of evidence-based alcohol screening in the Veterans Health Administration. Am J Manag Care 2006; 12:597.</a></li><li class="breakAll">US Department of Veterans Affairs Quality Enhancement Research Initiative. Clinical reminder for follow-up of positive alcohol use screen (AUDIT-C). http://www.queri.research.va.gov/tools/alcohol-misuse/alcohol-clinical-reminder-followup.cfm (Accessed on March 06, 2011).</li><li><a class="nounderline abstract_t">Williams EC, Achtmeyer CE, Kivlahan DR, et al. Evaluation of an electronic clinical reminder to facilitate brief alcohol-counseling interventions in primary care. J Stud Alcohol Drugs 2010; 71:720.</a></li><li><a class="nounderline abstract_t">Lapham GT, Achtmeyer CE, Williams EC, et al. Increased documented brief alcohol interventions with a performance measure and electronic decision support. Med Care 2012; 50:179.</a></li><li class="breakAll">US Department of Veterans Affairs Quality Enhancement Research Initiative. Alcohol Use Screening Clinical Reminder. http://www.queri.research.va.gov/tools/alcohol-misuse/alcohol-clinical-reminder-screening.cfm (Accessed on March 06, 2011).</li><li><a class="nounderline abstract_t">Kessler RC, Andrews G, Mroczek D, et al. The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF). Int J Methods Psychiatr Res 1997; 7:171.</a></li><li><a class="nounderline abstract_t">Hallgren KA, Matson TE, Oliver M, et al. Practical Assessment of Alcohol Use Disorder in Routine Primary Care: Performance of an Alcohol Symptom Checklist. J Gen Intern Med 2022; 37:1885.</a></li><li><a class="nounderline abstract_t">Vinson DC, Kruse RL, Seale JP. Simplifying alcohol assessment: two questions to identify alcohol use disorders. Alcohol Clin Exp Res 2007; 31:1392.</a></li><li><a class="nounderline abstract_t">Hawkins EJ, Malte CA, Gordon AJ, et al. Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System. JAMA Netw Open 2021; 4:e2137238.</a></li><li><a class="nounderline abstract_t">Wartko PD, Bobb JF, Boudreau DM, et al. Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial. JAMA Intern Med 2023; 183:1343.</a></li></ol></div><div id="topicVersionRevision">Topic 14843 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15010446" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Actual causes of death in the United States, 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15010446" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Actual causes of death in the United States, 2000.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15068984" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15068984" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: recommendation statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15703424" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Clinical practice. Unhealthy alcohol use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15703424" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Clinical practice. Unhealthy alcohol use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28793133" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16393194" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The extent of the 'prevention paradox' in alcohol problems as a function of population drinking patterns.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30422199" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515821" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Screening for Unhealthy Drug Use: US Preventive Services Task Force Recommendation Statement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515820" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515804" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Screening for Unhealthy Drug Use: Neither an Unreasonable Idea Nor an Evidence-Based Practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32515790" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Screening for Drug Use in Primary Care: Practical Implications of the New USPSTF Recommendation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8064641" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8064641" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Reliability and validity studies of the WHO--Composite International Diagnostic Interview (CIDI): a critical review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9564375" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Screening for problem drinking: does a single question work?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15797883" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Screening for hazardous or harmful drinking using one or two quantity-frequency questions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20625025" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A single-question screening test for drug use in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19247718" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Primary care validation of a single-question alcohol screening test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20731982" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Frequency of 5+/4+ drinks as a screener for drug use and drug-use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25986138" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Validation of Self-Administered Single-Item Screening Questions (SISQs) for Unhealthy Alcohol and Drug Use in Primary Care Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36871376" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Association between clinical measures of unhealthy alcohol use and subsequent year hospital admissions in a primary care population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35993432" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Using the alcohol use disorders identification test to predict hospital admission for alcohol-related conditions in the Danish general population: a record-linkage study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17451397" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : AUDIT-C as a brief screen for alcohol misuse in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20042299" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Estimating risk of alcohol dependence using alcohol screening scores.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12695273" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Two brief alcohol-screening tests From the Alcohol Use Disorders Identification Test (AUDIT): validation in a female Veterans Affairs patient population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8329970" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8329970" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10888972" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Screening for alcohol problems in primary care: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14972777" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Alcohol use disorders: screening and diagnosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22834916" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Use of AUDIT-based measures to identify unhealthy alcohol use and alcohol dependence in primary care: a validation study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8069168" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : A randomized clinical trial of brief interventions in primary care: summary of a WHO project.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4416585" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The CAGE questionnaire: validation of a new alcoholism screening instrument.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4416585" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The CAGE questionnaire: validation of a new alcoholism screening instrument.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20396975" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Prevalence and correlates of at-risk drinking among older adults: the project SHARE study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12494731" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Substance abuse in older adults. An overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25037298" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Substance abuse among older adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2712118" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The T-ACE questions: practical prenatal detection of risk-drinking.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8876514" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Detecting risk drinking during pregnancy: a comparison of four screening questionnaires.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20403013" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20403013" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Brief screening questionnaires to identify problem drinking during pregnancy: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25070067" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : An electronic screen for triaging adolescent substance use by risk levels.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12544008" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Validity of brief alcohol screening tests among adolescents: a comparison of the AUDIT, POSIT, CAGE, and CRAFFT.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12038895" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10357299" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : A new brief screen for adolescent substance abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20682942" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Adolescent alcohol use and violence: are brief interventions the answer?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19426168" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Cost-effectiveness of screening for unhealthy alcohol use with % carbohydrate deficient transferrin: results from a literature-based decision analytic computer model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7183189" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The drug abuse screening test.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26075352" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Screen of Drug Use: Diagnostic Accuracy of a New Brief Tool for Primary Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30933714" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Screen of drug use: Diagnostic accuracy for cannabis use disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30947051" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Screen of drug use: Diagnostic accuracy for opioid use disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32896784" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Screen of drug use: Diagnostic accuracy for stimulant use disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18373724" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Validation of the Alcohol, Smoking And Substance Involvement Screening Test (ASSIST).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11314930" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : A two-item conjoint screen for alcohol and other drug problems.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7778330" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Conjoint screening questionnaires for alcohol and other drug abuse: criterion validity in a primary care practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25770031" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : A Brief Patient Self-administered Substance Use Screening Tool for Primary Care: Two-site Validation Study of the Substance Use Brief Screen (SUBS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28550609" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Validation of the TAPS-1: A Four-Item Screening Tool to Identify Unhealthy Substance Use in Primary Care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17805340" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Validation of the 4P's Plus screen for substance use in pregnancy validation of the 4P's Plus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : High incidence of unhealthy alcohol use in older adult</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Should adults who screen negative for unhealthy substance use be rescreened annually?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22372573" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Involvement of general practitioners in managing alcohol problems: a randomized controlled trial of a tailored improvement programme.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25787012" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Professional's Attitudes Do Not Influence Screening and Brief Interventions Rates for Hazardous and Harmful Drinkers: Results from ODHIN Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23303891" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Effectiveness of screening and brief alcohol intervention in primary care (SIPS trial): pragmatic cluster randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25731916" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Factors Underlying Quality Problems with Alcohol Screening Prompted by a Clinical Reminder in Primary Care: A Multi-site Qualitative Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24773590" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26585638" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Physician versus non-physician delivery of alcohol screening, brief intervention and referral to treatment in adult primary care: the ADVISe cluster randomized controlled implementation trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34014326" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Comparison of Methods for Alcohol and Drug Screening in Primary Care Clinics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36848119" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Integrating Alcohol-Related Prevention and Treatment Into Primary Care: A Cluster Randomized Implementation Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37726839" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37844317" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Does Screening for Opioid Use Disorder in Primary Care Increase the Percentage of Patients With a New Diagnosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17026414" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Implementation of evidence-based alcohol screening in the Veterans Health Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17026414" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Implementation of evidence-based alcohol screening in the Veterans Health Administration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20731977" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Evaluation of an electronic clinical reminder to facilitate brief alcohol-counseling interventions in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881876" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Increased documented brief alcohol interventions with a performance measure and electronic decision support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881876" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Increased documented brief alcohol interventions with a performance measure and electronic decision support.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : The World Health Organization Composite International Diagnostic Interview Short-Form (CIDI-SF)</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34398395" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Practical Assessment of Alcohol Use Disorder in Routine Primary Care: Performance of an Alcohol Symptom Checklist.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17559544" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Simplifying alcohol assessment: two questions to identify alcohol use disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34870679" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37902748" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Nurse Care Management for Opioid Use Disorder Treatment: The PROUD Cluster Randomized Clinical Trial.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
